People

Amy Garrigues is a partner in the firm’s Chicago office with more than 15 years of experience advising the entire spectrum of healthcare industry clients on legal and business considerations. Amy leads healthcare-focused initiatives in the Midwest and represents regional and nationwide clients on a range of issues. Her practice concentrates on healthcare law, representing clients including hospitals, health systems, academic medical centers, private equity and investment management companies, ancillary service providers, and medical device companies.

Amy advises clients on all aspects of healthcare law, including but not limited to regulatory and compliance matters, False Claims Act, internal investigations, fraud and abuse laws including Stark and Anti-Kickback, and healthcare transactions. She counsels and serves as a strategic advisor to healthcare clients and Board of Directors. 

Before joining King & Spalding, Amy was the Executive Vice President and Chief Legal Officer for an international cancer care company and previously served on the Board of Directors and as an office managing partner of a national health law firm. Prior to her time as a lawyer, she worked as a healthcare strategy consultant with a global consulting firm.

 

Admitted only in North Carolina
Full Bio

Credentials

J.D., Harvard Law School

B.A., Harvard University, magna cum laude, Phi Beta Kappa

North Carolina

U.S. Court of Appeals for the Fourth Circuit

U.S. District Court for the Eastern District of North Carolina

American Bar Association, Health Law Section

American Health Law Association

North Carolina Bar, Health Law Section

North Carolina Society of Health Care Attorneys

Best Lawyers in America


2018

North Carolina Super Lawyers Rising Stars


2010

Icon close

Close

Recognition

Best Lawyers in America


2018

North Carolina Super Lawyers Rising Stars


2010

Matters

Advised and led international cancer care company through emergence from Chapter 11 bankruptcy restructuring, compliance with Corporate Integrity Agreement, successful completion of a Corrective Action Plan with the Office of Civil Rights, resolution of various significant, complex litigation matters involving fiduciary duties, noncompete laws, constitutional challenges, civil and criminal antitrust, managed care disputes, and the federal False Claims Act; formation of joint ventures with hospital partners and oral pharmacy; negotiation of a National Security Agreement; and completion of $1B sale process during the COVID-19 pandemic.

Led a significant number of confidential internal investigations on behalf of well-known academic medical center, university, publicly traded healthcare companies and other healthcare clients on highly sensitive matters carrying potential civil and criminal liability under healthcare, antitrust, physician misconduct, and other laws.

Routinely advises on government inquiries, potential compliance matters, potential violations of the federal Anti- Kickback Statute and/or the Stark Law, potential Medicare reimbursement matters, potential falsification of reports and claim submission or other documents, grant funding allocation issues and other matters.

See more
Icon close

Close

Matters

Advised and led international cancer care company through emergence from Chapter 11 bankruptcy restructuring, compliance with Corporate Integrity Agreement, successful completion of a Corrective Action Plan with the Office of Civil Rights, resolution of various significant, complex litigation matters involving fiduciary duties, noncompete laws, constitutional challenges, civil and criminal antitrust, managed care disputes, and the federal False Claims Act; formation of joint ventures with hospital partners and oral pharmacy; negotiation of a National Security Agreement; and completion of $1B sale process during the COVID-19 pandemic.

Led a significant number of confidential internal investigations on behalf of well-known academic medical center, university, publicly traded healthcare companies and other healthcare clients on highly sensitive matters carrying potential civil and criminal liability under healthcare, antitrust, physician misconduct, and other laws.

Routinely advises on government inquiries, potential compliance matters, potential violations of the federal Anti- Kickback Statute and/or the Stark Law, potential Medicare reimbursement matters, potential falsification of reports and claim submission or other documents, grant funding allocation issues and other matters.

Served as lead regulatory transactional counsel in significant private equity acquisitions of healthcare providers and IT companies and in corresponding entry into credit and other financing agreements.

Lead counsel on behalf of various hospitals and health systems in resolution of multiple False Claims Act inquiries and lawsuits related to various fraud and abuse, Medicare and Medicaid reimbursement issues, and associated retaliation claims.

Represented an academic medical center in government inquiries and successful resolution of False Claims Act litigation related to teaching physician supervision and medical direction of anesthesia services.

Represented an international cancer care company in resolution of False Claims Act cases involving allegations related to medical necessity of lab tests, compliance with meaningful use and EHR incentive programs, Stark and Anti-Kickback compliance in physician compensation and group practice matters.

Represented numerous providers in connection with negotiation and successful implementation of Corporate Integrity Agreements.

Represented hospitals and health systems in connection with Office of Inspector General billing and compliance audits and other inquiries.

Represented a large health system in connection with litigation with the Department of Health and Human Services related to a potential writ of mandamus to compel ALJ hearings within the prescribed regulatory time frame.

Represented multiple healthcare providers in multiple hearings related to compliance with EMTALA.

Represented multiple hospitals and health systems across the country in connection with self-disclosures to the government under the federal Stark and Anti-Kickback Laws and related resolutions.

Represented hospitals in connection with ambulatory surgery center private placements.

Represented multiple hospitals and health systems in Stark and AKS matters that resulted in decisions that activities were reasonably compliant and a self-disclosure was not warranted.

Conducted internal investigations at hospitals, academic medical centers and other healthcare provider clients related to a number of allegations potentially implicating the FCA, including but not limited to those covering: (i) allegations of Stark and anti-kickback noncompliance related to physician compensation; (ii) allegations of receipt of improper benefits from a medical device company; (iii) allegations of improper receipt of products from pharmaceutical companies and potential provision of free services to government beneficiaries; (iv) allegations of noncompliance by former executives post-termination; (v) allegations of distributing free items to referring physicians; (vi) allegations of lack of physician presence in the operating room setting; (vii) receipt of meaningful use payments; and (viii) improper inpatient billing for certain services.

Matters

Advised and led international cancer care company through emergence from Chapter 11 bankruptcy restructuring, compliance with Corporate Integrity Agreement, successful completion of a Corrective Action Plan with the Office of Civil Rights, resolution of various significant, complex litigation matters involving fiduciary duties, noncompete laws, constitutional challenges, civil and criminal antitrust, managed care disputes, and the federal False Claims Act; formation of joint ventures with hospital partners and oral pharmacy; negotiation of a National Security Agreement; and completion of $1B sale process during the COVID-19 pandemic.

Led a significant number of confidential internal investigations on behalf of well-known academic medical center, university, publicly traded healthcare companies and other healthcare clients on highly sensitive matters carrying potential civil and criminal liability under healthcare, antitrust, physician misconduct, and other laws.

Routinely advises on government inquiries, potential compliance matters, potential violations of the federal Anti- Kickback Statute and/or the Stark Law, potential Medicare reimbursement matters, potential falsification of reports and claim submission or other documents, grant funding allocation issues and other matters.

See more
Icon close

Close

Matters

Advised and led international cancer care company through emergence from Chapter 11 bankruptcy restructuring, compliance with Corporate Integrity Agreement, successful completion of a Corrective Action Plan with the Office of Civil Rights, resolution of various significant, complex litigation matters involving fiduciary duties, noncompete laws, constitutional challenges, civil and criminal antitrust, managed care disputes, and the federal False Claims Act; formation of joint ventures with hospital partners and oral pharmacy; negotiation of a National Security Agreement; and completion of $1B sale process during the COVID-19 pandemic.

Led a significant number of confidential internal investigations on behalf of well-known academic medical center, university, publicly traded healthcare companies and other healthcare clients on highly sensitive matters carrying potential civil and criminal liability under healthcare, antitrust, physician misconduct, and other laws.

Routinely advises on government inquiries, potential compliance matters, potential violations of the federal Anti- Kickback Statute and/or the Stark Law, potential Medicare reimbursement matters, potential falsification of reports and claim submission or other documents, grant funding allocation issues and other matters.

Served as lead regulatory transactional counsel in significant private equity acquisitions of healthcare providers and IT companies and in corresponding entry into credit and other financing agreements.

Lead counsel on behalf of various hospitals and health systems in resolution of multiple False Claims Act inquiries and lawsuits related to various fraud and abuse, Medicare and Medicaid reimbursement issues, and associated retaliation claims.

Represented an academic medical center in government inquiries and successful resolution of False Claims Act litigation related to teaching physician supervision and medical direction of anesthesia services.

Represented an international cancer care company in resolution of False Claims Act cases involving allegations related to medical necessity of lab tests, compliance with meaningful use and EHR incentive programs, Stark and Anti-Kickback compliance in physician compensation and group practice matters.

Represented numerous providers in connection with negotiation and successful implementation of Corporate Integrity Agreements.

Represented hospitals and health systems in connection with Office of Inspector General billing and compliance audits and other inquiries.

Represented a large health system in connection with litigation with the Department of Health and Human Services related to a potential writ of mandamus to compel ALJ hearings within the prescribed regulatory time frame.

Represented multiple healthcare providers in multiple hearings related to compliance with EMTALA.

Represented multiple hospitals and health systems across the country in connection with self-disclosures to the government under the federal Stark and Anti-Kickback Laws and related resolutions.

Represented hospitals in connection with ambulatory surgery center private placements.

Represented multiple hospitals and health systems in Stark and AKS matters that resulted in decisions that activities were reasonably compliant and a self-disclosure was not warranted.

Conducted internal investigations at hospitals, academic medical centers and other healthcare provider clients related to a number of allegations potentially implicating the FCA, including but not limited to those covering: (i) allegations of Stark and anti-kickback noncompliance related to physician compensation; (ii) allegations of receipt of improper benefits from a medical device company; (iii) allegations of improper receipt of products from pharmaceutical companies and potential provision of free services to government beneficiaries; (iv) allegations of noncompliance by former executives post-termination; (v) allegations of distributing free items to referring physicians; (vi) allegations of lack of physician presence in the operating room setting; (vii) receipt of meaningful use payments; and (viii) improper inpatient billing for certain services.

Credentials

J.D., Harvard Law School

B.A., Harvard University, magna cum laude, Phi Beta Kappa

North Carolina

U.S. Court of Appeals for the Fourth Circuit

U.S. District Court for the Eastern District of North Carolina

American Bar Association, Health Law Section

American Health Law Association

North Carolina Bar, Health Law Section

North Carolina Society of Health Care Attorneys

Best Lawyers in America


2018

North Carolina Super Lawyers Rising Stars


2010

Icon close

Close

Recognition

Best Lawyers in America


2018

North Carolina Super Lawyers Rising Stars


2010